Innovation and Translation

EMBL boasts some of the best scientific talent in Europe. Get in touch.

The European Molecular Biology Laboratory employs some of the greatest minds in European science. Our talent pool boasts biologists, engineers, IT professionals and countless other scientific specialisations. In addition, EMBL research has many practical and industrial applications

We harness EMBL’s entrepreneurial spirit through technology transfer programmes and technology spin-offs.

Technology transfer

EMBLEM

EMBL Enterprise Management Technology Transfer GmbH (EMBLEM) is an affiliate and the commercial arm of the European Molecular Biology Laboratory (EMBL). Established in 1999, EMBLEM identifies, protects and commercialises the intellectual property developed at EMBL, by EMBL alumni and by non-EMBL third parties. EMBLEM works closely with industrial partners in the biotech, IT and engineering markets to accelerate the transfer of innovative technology from basic research to industry.

EMBLEM manages a portfolio of close to 300 individual patents, patent applications, copyrights, trademarks and utility models. The technology portfolio, which spans the life sciences, includes enabling technologies, scientific instruments, molecular tools and techniques, as well as software programmes and databases.

EMBL Programmes

Corporate Partnership Programme

The Programme is designed to form and cultivate long-term, fruitful relationships between EMBL and top-class corporate partners.

EMBL-EBI Industry Programme

A forum for interaction and knowledge exchange for those employed at the forefront of industrial bioinformatics.

Open Targets

A freely-available, large-scale, multi-year, public-private partnership that uses human genetics and genomics data for systematic drug target identification and prioritisation.

Agri-Tech Partnership

The Agri-Tech Partnership establishes collaboration with domain experts in advanced agricultural technologies from both public and private sectors.

Venture capital

EMBL Ventures

Based in Heidelberg, Germany, EMBL Ventures invest throughout Europe to build companies that create significant commercial opportunities based on new therapeutic-treatment modalities and pharmaceuticals, next-generation enabling-technology platforms or innovations in the diagnostics and medical device area.

As an independent and focused team, EMBL Ventures moves quickly with short decision timelines.

Latest

Industry news from EMBL’s six sites

Latest Jobs

See more jobs